Patent classifications
C
C07
C07K
5/00
C07K5/04
C07K5/06
C07K5/06008
C07K5/06008
Polyconjugates for Delivery of RNAi triggers to Tumor Cells In Vivo
20170022497
·
2017-01-26
·
The present invention is directed compositions for delivery of RNA interference (RNAi) triggers to integrin positive tumor cells in vivo. The compositions comprise RGD ligand-targeted amphipathic membrane active polyamines reversibly modified with enzyme cleavable dipeptide-amidobenzyl-carbonate masking agents. Modification masks membrane activity of the polymer while reversibility provides physiological responsiveness. The reversibly modified polyamines (dynamic polyconjugate or conjugate) are further covalently linked to an RNAi trigger.
Drug-Conjugates, Conjugation Methods, And Uses Thereof
In one aspect, an active agent-conjugate, methods of preparing the active agent-conjugate, and uses thereof is provided.